Metabolic acidosis also has other effects, including changing free concentrations to bound concentrations of calcium and magnesium, which impact on cellular ion fluxes, electrical gradients and neurotransmission, and also the protein binding of both azotaemic toxins and drugs that could affect their therapeutic effectiveness and also could result in accumulation and neurotoxicity [ 41].
Interestingly while neutralizing antibodies to the binding domains of both toxin A and B are moderately protective, enhanced survival is observed when fragments from the glucosyltransferase region of toxin B replace those from the binding domain of this toxin.
It has been reported that increased expression of GBGT1 reduces the susceptibility to microbial toxins (e.g., Shiga toxins) because Forssman glycolipids, which do not bind microbial toxins, are thought to inhibit the binding of toxin by replacing toxin-binding glycolipid [28].
All sdAb were capable of binding both toxin and toxin complex suggesting that 1) either the sdAb targeted epitopes on the toxin not shielded by the complex of NAP proteins as seen with some scFv [34], or 2) the toxin complexes were disassembled and were not shielding the toxin effectively.
Interestingly, most recent data obtained by solid-state NMR suggest that obviously during the binding of peptide toxins to their target, some conformational changes on both binding partners occur (Lange et al. 2006).
It has been suggested that the initial phase is a direct consequence of the binding of the toxins to nerve terminals.
We chose to examine the binding of the [Lys]-fullerene to Kv1.3, giving us the opportunity to directly compare our results with the binding of polypeptide toxins [37, 38].
The most significant progress is the development of highly potent multivalent ligands that block binding of the toxins to their receptors.
This study provides insight into the key molecular determinants for the high-affinity binding of peptide toxins to KCa3.1, and demonstrates the power of computational methods in the design of novel toxins.
The application solutions with the different toxins and blockers were applied locally using perfusion tubing coated with Sigmacote (Sigma) to prevent binding of the toxins.
